Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants

Arturo Abdelnour, Peter E. Silas, Marta Raquel Valdés Lamas, Carlos Fernándo Grazioso Aragón, Nan Chang Chiu, Cheng Hsun Chiu, Teobaldo Herrera Acuña, Tirza De León Castrejón, Allen Izu, Tatjana Odrljin, Igor Smolenov, Matthew Hohenboken, Peter M. Dull*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants'. Together they form a unique fingerprint.

Immunology and Microbiology